Pluri (PLUR) Cost of Revenue (2011 - 2025)
Pluri (PLUR) reported Cost of Revenue of $497000.0 for Q4 2025, up 571.62% year-over-year from $74000.0 in Q4 2024, and up 147.26% quarter-over-quarter from $201000.0 in Q3 2025.
Pluri (PLUR) Cost of Revenue (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 11 years of Cost of Revenue data on file, last reported at $497000.0 in Q4 2025.
- Cost of Revenue for Q4 2025 came in at $497000.0, up 571.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 million (up 478.43% YoY), and the FY2025 annual result was $682000.0, up 16950.0% from the prior year.
- Cost of Revenue rose to $497000.0 in Q4 2025 per PLUR's latest filing, from $201000.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $497000.0 in Q4 2025 and troughed at $4000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 2.05 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 497,000.00 |
| Dec 31, 2025 | 497,000.00 |
| Sep 30, 2025 | 201,000.00 |
| Sep 30, 2025 | 201,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |